+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Meropenem"

Antibiotic Resistance Global Market Report 2024 - Product Thumbnail Image

Antibiotic Resistance Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Carbapenem-based Antibiotics Global Market Report 2024 - Product Thumbnail Image

Carbapenem-based Antibiotics Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
From
From
From
  • 8 Results (Page 1 of 1)
Loading Indicator

Meropenem is an antibiotic used to treat a wide range of bacterial infections. It belongs to a class of antibiotics known as carbapenems, which are used to treat infections caused by Gram-negative bacteria. Meropenem is effective against a broad range of bacteria, including those that are resistant to other antibiotics. It is commonly used to treat infections of the urinary tract, skin, and soft tissue, as well as pneumonia and meningitis. Meropenem is also used to treat infections caused by multi-drug resistant bacteria. Meropenem is available in both intravenous and oral formulations. It is typically administered as an intravenous infusion over a period of 30 minutes to one hour. The oral formulation is taken twice daily. Meropenem is generally well tolerated, with the most common side effects being nausea, vomiting, and diarrhea. The Meropenem market is highly competitive, with several major players offering a range of products. These include Merck & Co., Pfizer, GlaxoSmithKline, AstraZeneca, and Sanofi. Other companies in the market include Allergan, Daiichi Sankyo, and Teva Pharmaceuticals. Show Less Read more